Dosology becomes national with the whole foods market

VERNON, BC, November 25, 2022 /CNW/ – Doseology Sciences Inc. (CS: HUMOR) (OTCQB: DOSEF) (FS: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce that its functional mushroom supplements will soon be available nationwide in all 14 high-end locations. level of Whole Foods Market Canada.

Logo of Doseology Sciences Inc. (CNW Group/Doseology Sciences Inc.)

The company launched with 3 main SKUs: SLEEP, WAKE and ELEVATE functional mushroom tinctures. Doseology’s products can currently be found in Western retail locations at Whole Foods Market in West Vancouver, North Vancouver, VancouverAnd Northern Burnabyand will soon be available in all Canadian outlets.

“Whole Foods has a reputation as an industry leader with the highest standards, making them an ideal partner for retailing our products. This position will help us generate brand awareness and increase sales, while delivering results of health and wellness for customers,” he said Ralph OlsonChief Executive Officer of the Company.

The line is made with 100% fruiting body fungi and adaptogenic plants and is designed for wellness seekers interested in daily support for cognition, mood, immunity, and relaxation.

Approximately 30% of Canadians suffer from sleep disorders (The Sleep Foundation). Sleep affects mental health and physical well-being and is linked to the majority of mood disorders, including depression and anxiety (Provincial Health Services Authority). To address this problem, Doseology has formulated its own TO SLEEP dyeing. The proprietary blend of reishi mushroom, chamomile and melatonin is a powerful tool that brings the body and mind into a state of rest and improves the quality of sleep. The Reishi Mushroom (Ganoderma lucidum), also known as the “Immortality Mushroom”, has been used for centuries to relieve stress and anxiety.

Mornings are supercharged with Doseology WAKE dyeing. It is an energizing blend of lion’s mane mushroom, yerba mate and B vitamins to promote wakefulness and mental clarity. Wake was recently seen in “Four surprising wellness trends for 2023“.

The dosiology ELEVATE the tincture features lion’s mane, the mushroom known to unlock cognitive potential, and is formulated with a nutrient-rich dose of ginger and vitamin B3. These consciously stacked ingredients work synergistically to offer support for overall mood.

On behalf of Doseology Sciences Inc.
Ralph Olson
CEO

About Whole Foods Market

For more than 40 years, Whole Foods Market has been a leading retailer of natural and organic foods. Whole Foods seeks out the best natural and organic foods available, maintains the strictest quality standards in the industry, and has an unwavering commitment to sustainable agriculture. Whole Foods has more than 500 stores across the United States, Canada and the United Kingdom. It has 14 outlets in Canadaof which 7 in British Columbiaand 7 are inside Ontario. Whole Foods is a subsidiary of Amazon (Nasdaq: AMZ extension).

Learn about the sciences of dosiology (CSE: HUMOR) (OTCQB: DOSEF) (ESF: VU7)

Doseology Sciences Inc. is building a progressive brand focused on mental health and wellness through cultivation, extraction, and innovative nutraceutical and pharmaceutical products. Dosiology aims to have a significant impact on the mental health pandemic by using and developing functional fungi and plant-derived drugs. With a vertically integrated approach, Doseology intends to process and distribute the products at its facilities in Vernon, British Columbia, in accordance with applicable laws to ensure safe and high-quality production. Doseology’s medicinal mushroom products, including tinctures, powders and supplements, are available at doseology. com.

Website: doseology. com

Forward-Looking Statements

This press release contains statements that constitute “forward-looking information” under applicable securities laws. Forward-looking information is often identified by the words “may”, “would like”, “may”, “should”, “will”, “intends”, “plans”, “anticipates”, “believes”, “estimates” “expects” or similar expressions. Readers are cautioned that the forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or projections regarding the Company’s business, future results or events based on the Company’s opinions, assumptions and estimates. management deemed reasonable at the date the statements are made. While the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or hits. Some of the key factors that could cause actual results to differ materially from those projected in the forward-looking information include the following: changes in general economic, business and political conditions, including changes in financial markets; declines in prevailing prices for products in the markets in which the Company operates; adverse changes in applicable laws or adverse changes in the application or compliance with applicable laws; regulations and enforcement priorities of government authorities; compliance with government regulations and related costs; and other risks described in the Company’s prospectus. If one or more of these risks or uncertainties materialize, or if assumptions underlying the forward-looking information prove incorrect, actual results could vary materially from those described herein as anticipated, planned, anticipated, believed, estimated, or expected. While the Company has attempted to identify risks, uncertainties and important factors that could cause actual results to differ materially, there could be others that cause results to not be as expected, estimated or expected. The Company does not intend and undertakes no obligation to update this forward-looking information except as otherwise required by applicable law. For further information, investors should consult the Company’s documents available at SEDAR.

No securities regulatory authority has approved or disapproved the contents of this press release. The Company’s securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under any state securities law, and may not be offered or sold in the United Statesor to or for the account or benefit of any person in the United States, no registration, or an applicable exemption from the registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities the United Statesor in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

The CSE assumes no responsibility for the adequacy or accuracy of this release.

SOURCE Doseology Sciences Inc.

cision

cision

View original content to download media: http://www.newswire.ca/en/releases/archive/November2022/25/c5549.html

Leave a Reply

%d bloggers like this: